Ningbo David Medical Device Co., Ltd. (300314.SZ)
CNY 12.42
(2.14%)
CNY 12.42
(2.14%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 135.19 Million | 111.56 Million | 51.48 Million | 137.73 Million | 88.56 Million | 69.95 Million |
| Net Income | 147.61 Million | 97.57 Million | 80.2 Million | 136.19 Million | 62.05 Million | 28.81 Million |
| Depreciation & Amortization | 27.32 Million | 25.5 Million | 24.54 Million | 21.48 Million | 21.07 Million | 20.75 Million |
| Deferred income taxes | -618 Thousand | 891.72 Thousand | -406.64 Thousand | -76.36 Thousand | -144.58 Thousand | 153.41 Thousand |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -25.97 Million | -1.44 Million | -42.01 Million | 23.5 Million | 18.65 Million | 17.23 Million |
| Other non-cash items | -13.75 Million | -10.06 Million | -11.25 Million | -43.45 Million | -13.22 Million | 3.15 Million |
| Investing Cash Flow | 71.76 Million | -40.84 Million | 106.69 Million | -131.61 Million | 23.94 Million | -86.84 Million |
| Investments in PPE | -40.39 Million | -49.77 Million | -6.53 Million | -24.2 Million | -9.08 Million | -15.23 Million |
| Acquisitions | 592.48 Thousand | 22.45 Thousand | 281.95 Thousand | 105.63 Thousand | 103.29 Thousand | 1.3 Million |
| Investment purchases | -2.5 Million | -2.5 Million | -6.5 Million | -1 Million | -1.3 Billion | -1.04 Billion |
| Sales/Maturities of investments | 16.96 Million | 11.4 Million | 19.44 Million | 13.47 Million | 12.91 Million | 27.08 Million |
| Other Investing Activities | 97.1 Million | 0.45 | 100 Million | -119.99 Million | 1.32 Billion | -98.69 Million |
| Financing Cash Flow | -45.7 Million | -32.88 Million | -43.67 Million | -11.52 Million | -25.92 Million | -14.4 Million |
| Debt repayment | -2.5 Million | -4.08 Million | -472.22 Thousand | - | - | - |
| Dividends payments | -43.2 Million | -28.8 Million | -43.2 Million | -11.52 Million | -25.92 Million | -14.4 Million |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -2.5 Million | -0.98 | -472.22 Thousand | - | - | - |
| Accounts receivables | -9.04 Million | -5.59 Million | -3.13 Million | -1.71 Million | -10.97 Million | 12.34 Million |
| Accounts payables | -4.03 Million | 14.66 Million | -3.16 Million | 38.83 Million | 43.07 Million | 5.67 Million |
| Inventory | -12.26 Million | -11.4 Million | -35.3 Million | -13.53 Million | -13.3 Million | -933.48 Thousand |
| Other working capital | -618 Thousand | 891.72 Thousand | -406.64 Thousand | -76.36 Thousand | -144.59 Thousand | 18.16 Million |
| Cash at beginning of period | 389.87 Million | 334.99 Million | 223.35 Million | 232.06 Million | 145.58 Million | 173.35 Million |
| Cash at end of period | 557.45 Million | 389.87 Million | 334.99 Million | 223.35 Million | 232.06 Million | 145.58 Million |
| Capital Expenditure | -40.39 Million | -49.77 Million | -6.53 Million | -24.2 Million | -9.08 Million | -15.23 Million |
| Effect of forex changes on cash | 6.32 Million | 17.04 Million | -2.86 Million | -3.3 Million | -106.17 Thousand | 3.51 Million |
| Net cash flow / Change in cash | 167.58 Million | 54.88 Million | 111.63 Million | -8.71 Million | 86.48 Million | -27.77 Million |
| Free Cash Flow | 94.8 Million | 61.79 Million | 44.94 Million | 113.52 Million | 79.48 Million | 54.71 Million |
| Breakdown | 2024 Q3 | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | 8.41 Million | 38.1 Million | 24.81 Million | 147.61 Million | 31.01 Million |
| Depreciation & Amortization | - | 7.26 Million | 7.26 Million | 6.93 Million | 27.32 Million | -13.26 Million |
| Deferred income taxes | - | - | - | - | -618 Thousand | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | - | -21.31 Million | -25.97 Million | 21.15 Million |
| Other non-cash items | - | 12.27 Million | -47.85 Million | 54.83 Million | -13.75 Million | -6.55 Million |
| Investing Cash Flow | -30.81 Million | -133.42 Million | -104.32 Million | 3.87 Million | 71.76 Million | 18.49 Million |
| Investments in PPE | -33.12 Million | -43.42 Million | -34.32 Million | -17.77 Million | -40.39 Million | -13.78 Million |
| Acquisitions | - | - | - | 341.38 Thousand | 592.48 Thousand | 9000.00 |
| Investment purchases | - | - | -20 Million | -1.14 Billion | -2.5 Million | 630 Million |
| Sales/Maturities of investments | 2.3 Million | 2.31 Million | 587.09 Thousand | 1.31 Million | 16.96 Million | 2.27 Million |
| Other Investing Activities | 265.49 | -90 Million | -50 Million | 1.16 Billion | 97.1 Million | -599.99 Million |
| Financing Cash Flow | -34.37 Million | -21.03 Million | -1.00 | -614.03 Thousand | -45.7 Million | -1.89 Million |
| Debt repayment | - | - | - | - | -2.5 Million | - |
| Dividends payments | -34.24 Million | - | - | - | -43.2 Million | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | -125.4 Thousand | -17.59 Million | - | -614.03 Thousand | -2.5 Million | -1.89 Million |
| Accounts receivables | - | - | - | -9.04 Million | -9.04 Million | 18.7 Million |
| Accounts payables | - | - | - | - | -4.03 Million | - |
| Inventory | - | - | - | -12.26 Million | -12.26 Million | 2.44 Million |
| Other working capital | - | - | - | - | -618 Thousand | - |
| Cash at beginning of period | 302.59 Million | 456.25 Million | 571.36 Million | 488.63 Million | 389.87 Million | 440.72 Million |
| Cash at end of period | 249.16 Million | 316.02 Million | 456.25 Million | 557.45 Million | 557.45 Million | 488.63 Million |
| Capital Expenditure | -33.12 Million | -43.42 Million | -34.32 Million | -17.77 Million | -40.39 Million | -13.78 Million |
| Effect of forex changes on cash | -1.48 Million | 535.9 Thousand | -297.65 Thousand | 293.29 Thousand | 6.32 Million | -677.3 Thousand |
| Net cash flow / Change in cash | -53.43 Million | -140.23 Million | -115.1 Million | 68.82 Million | 167.58 Million | 47.9 Million |
| Free Cash Flow | -33.12 Million | -29.99 Million | -44.07 Million | 47.48 Million | 94.8 Million | 18.57 Million |
AGILC
CLCO
600587
ALPA3
ELMA
AZM